Citius Pharmaceuticals (Citius Pharmaceuticals) Other Stockholders Equity : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Citius Pharmaceuticals Other Stockholders Equity?

Citius Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Mar. 2024 was $0.00 Mil.

Citius Pharmaceuticals's quarterly Other Stockholders Equity increased from Sep. 2023 ($-0.00 Mil) to Dec. 2023 ($-0.00 Mil) and increased from Dec. 2023 ($-0.00 Mil) to Mar. 2024 ($0.00 Mil).

Citius Pharmaceuticals's annual Other Stockholders Equity stayed the same from Sep. 2021 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then declined from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($-0.00 Mil).

Citius Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Citius Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Pharmaceuticals Other Stockholders Equity Chart

Citius Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Stockholders Equity

Get a 7-Day Free Trial

Citius Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Citius Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Citius Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Citius Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Pharmaceuticals (Citius Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Citius Pharmaceuticals Inc (NAS:CTXRW) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CTXR:USA 47N:Germany

Address

11 Commerce Drive, First Floor, Cranford, NJ, USA, 07016

Website

http://www.citiuspharma.com

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.